CAS RN: 1623060-27-4
Methyl 5,6,7,8-tetrahydroiMidazo[1,2-a]pyridine-7-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260609
1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1623060-27-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
1623060-27-4 / methyl 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-7-carboxylate
Standard CAS: 1623060-27-4
Multi CAS: No
Basic Information
copy
CAS
1623060-27-4 copy
Multi CAS
No copy
Molecular Formula
C9H12N2O2 copy
Molecular Weight
180.200000 copy
Exact Mass
180.089878 copy
SMILES
COC(=O)C1CCN2C=CN=C2C1 copy
InChI
InChI=1S/C9H12N2O2/c1-13-9(12)7-2-4-11-5-3-10-8(11)6-7/h3,5,7H,2,4,6H2,1H3 copy
InChIKey
DDAIQFYELLGXRT-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.56 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
Molar refractivity
46.05 copy
TPSA
44.12 copy
LogP / Solubility
WLOGP
0.62 copy
MLOGP
0.54 copy
XLogP3
0.2 copy
Consensus LogP
0.45 copy
Log S (ESOL)
-1.57 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.48 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.46 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.38 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy